デフォルト表紙
市場調査レポート
商品コード
983298

潜在性結核感染症の世界市場:COVID-19の影響、検査(ツベルクリン皮膚検査(TST)、インターフェロンガンマ放出アッセイ(IGRA))、エンドユーザー、地域別の分析、2027年までの予測

Latent TB Detection Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Test (Tuberculin Skin Test (TST) and Interferon Gamma Released Assay (IGRA)); End User (Hospitals, Diagnostic Centers, Laboratories, and Others) and Geography

出版日: | 発行: The Insight Partners | ページ情報: 英文 137 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.07円
潜在性結核感染症の世界市場:COVID-19の影響、検査(ツベルクリン皮膚検査(TST)、インターフェロンガンマ放出アッセイ(IGRA))、エンドユーザー、地域別の分析、2027年までの予測
出版日: 2021年04月09日
発行: The Insight Partners
ページ情報: 英文 137 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の潜在性結核感染症市場は、2019年に11億3,182万米ドルとなりました。同市場は、2020年から2027年にかけて5.2%のCAGRで成長する見通しで、2027年には16億8,486万米ドルに達すると予測されています。同市場の成長は、結核の有病率の増加や結核の検出を促進する政府のイニシアチブなど、複数の要因に起因しています。ただし、多剤耐性結核(MDR-TB)の存在は、市場成長を妨げる可能性があります。

当レポートは、世界の潜在性結核感染症市場について調査しており、市場収益や予測、機会や動向、成長および抑制要因、COVID-19パンデミックの影響、検査・エンドユーザー・地域別の市場分析、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 イントロダクション

第2章 要点

第3章 調査手法

第4章 市場情勢

  • 概要
  • PEST分析

第5章 主な市場力学

  • 市場の成長要因
  • 市場の抑制要因
  • 市場機会
  • 今後の動向
  • 影響分析

第6章 世界市場分析

  • 世界市場の収益予測と分析
  • 地域別市場:予測と分析
  • 主要企業の市場の位置付け

第7章 市場分析:検査別

  • 概要
  • 市場シェア(2019,2027)
  • ツベルクリン皮膚検査(TST)
  • インターフェロンガンマリリースアッセイ(IGRA)

第8章 市場分析:エンドユーザー別

  • 概要
  • 市場シェア(2019,2027)
  • 病院
  • 診断センター

第9章 市場分析:地域別

  • 北米
  • 欧州
  • アジア太平洋
  • 中東・アフリカ
  • 中南米

第10章 COVID-19パンデミックの影響

  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第11章 業界情勢

  • 概要
  • 市場企業の成長戦略
  • 有機的開発
  • 無機的開発

第12章 企業プロファイル

  • QIAGEN
  • bioMerieux SA
  • F. HOFFMANN-LA ROCHE LTD.
  • BD
  • Abbott
  • Oxford Immunotec Ltd
  • Lionex GmbH
  • ARKRAY, Inc.
  • Serum Institute of India Pvt. Ltd

第13章 付録

  • The Insight Partners について
  • 用語集
図表

List Of Tables

  • Table 1. North America: Latent TB Detection Market, by Test - Revenue and Forecast to 2027 (USD Million)
  • Table 2. North America: Latent TB Detection Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 3. US: Latent TB Detection Market, by Test - Revenue and Forecast to 2027 (USD Million)
  • Table 4. US: Latent TB Detection Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 5. Canada: Latent TB Detection Market, by Test - Revenue and Forecast to 2027 (USD Million)
  • Table 6. Canada: Latent TB Detection Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 7. Mexico: Latent TB Detection Market, by Test - Revenue and Forecast to 2027 (USD Million)
  • Table 8. Mexico: Latent TB Detection Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 9. Europe: Latent TB Detection Market, by Test - Revenue and Forecast to 2027 (USD Million)
  • Table 10. Europe: Latent TB Detection Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 11. Germany: Latent TB Detection Market, by Test - Revenue and Forecast to 2027 (USD Million)
  • Table 12. Germany: Latent TB Detection Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 13. UK: Latent TB Detection Market, by Test - Revenue and Forecast to 2027 (USD Million)
  • Table 14. UK: Latent TB Detection Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 15. France: Latent TB Detection Market, by Test - Revenue and Forecast to 2027 (USD Million)
  • Table 16. France: Latent TB Detection Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 17. Italy: Latent TB Detection Market, by Test - Revenue and Forecast to 2027 (USD Million)
  • Table 18. Italy: Latent TB Detection Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 19. Spain: Latent TB Detection Market, by Test - Revenue and Forecast to 2027 (USD Million)
  • Table 20. Spain: Latent TB Detection Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 21. Rest of Europe: Latent TB Detection Market, by Test - Revenue and Forecast to 2027 (USD Million)
  • Table 22. Rest of Europe: Latent TB Detection Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 23. Asia Pacific Latent TB Detection Market, by Test- Revenue and Forecast to 2027 (USD Million)
  • Table 24. Asia Pacific Latent TB Detection Market, by End User- Revenue and Forecast to 2027 (USD Million)
  • Table 25. China Latent TB Detection Market, by Test- Revenue and Forecast to 2027 (USD Million)
  • Table 26. China Latent TB Detection Market, by End User- Revenue and Forecast to 2027 (USD Million)
  • Table 27. Japan Latent TB Detection Market, by Test- Revenue and Forecast to 2027 (USD Million)
  • Table 28. Japan Latent TB Detection Market, by End User- Revenue and Forecast to 2027 (USD Million)
  • Table 29. India Latent TB Detection Market, by Test- Revenue and Forecast to 2027 (USD Million)
  • Table 30. India Latent TB Detection Market, by End User- Revenue and Forecast to 2027 (USD Million)
  • Table 31. South Korea Latent TB Detection Market, by End User- Revenue and Forecast to 2027 (USD Million)
  • Table 32. South Korea Latent TB Detection Market, by End User- Revenue and Forecast to 2027 (USD Million)
  • Table 33. Australia Latent TB Detection Market, by Test- Revenue and Forecast to 2027 (USD Million)
  • Table 34. Australia Latent TB Detection Market, by End User- Revenue and Forecast to 2027 (USD Million)
  • Table 35. Middle East and Africa Latent TB Detection Market, by Test- Revenue and Forecast to 2027 (USD Million)
  • Table 36. Middle East and Africa Latent TB Detection Market, by End User- Revenue and Forecast to 2027 (USD Million)
  • Table 37. Saudi Arabia Latent TB Detection Market, by Test- Revenue and Forecast to 2027 (USD Million)
  • Table 38. Saudi Arabia Latent TB Detection Market, by End User- Revenue and Forecast to 2027 (USD Million)
  • Table 39. UAE Latent TB Detection Market, by Test- Revenue and Forecast to 2027 (USD Million)
  • Table 40. UAE Latent TB Detection Market, by End User- Revenue and Forecast to 2027 (USD Million)
  • Table 41. South Africa Latent TB Detection Market, by Test- Revenue and Forecast to 2027 (USD Million)
  • Table 42. South Africa Latent TB Detection Market, by End User- Revenue and Forecast to 2027 (USD Million)
  • Table 43. South and Central America Latent TB Detection Market, by Test- Revenue and Forecast to 2027 (USD Million)
  • Table 44. South and Central America Latent TB Detection Market, by End User- Revenue and Forecast to 2027 (USD Million)
  • Table 45. Brazil Latent TB Detection Market, by Test- Revenue and Forecast to 2027 (USD Million)
  • Table 46. Brazil Latent TB Detection Market, by End User- Revenue and Forecast to 2027 (USD Million)
  • Table 47. Argentina Latent TB Detection Market, by Test- Revenue and Forecast to 2027 (USD Million)
  • Table 48. Argentina Latent TB Detection Market, by End User- Revenue and Forecast to 2027 (USD Million)
  • Table 49. Organic Developments Done By Companies
  • Table 50. Inorganic Developments Done By Companies
  • Table 51. Glossary of Terms, Latent TB Detection Market

List Of Figures

  • Figure 1. Latent TB Detection Market Segmentation
  • Figure 2. Latent TB Detection Market - By Geography
  • Figure 3. Global Latent TB Detection Market Overview
  • Figure 4. Tuberculin Skin Test (TST) Segment Held Largest Share of Latent TB Detection Market
  • Figure 5. Asia-Pacific to Show Remarkable Growth During Forecast Period
  • Figure 6. Global Latent TB Detection Market, By Geography (US$ Million)
  • Figure 7. Global Latent TB Detection Market - Leading Country Markets (US$ Million)
  • Figure 8. Global Latent TB Detection Market, Industry Landscape
  • Figure 9. North America PEST Analysis
  • Figure 10. Europe PEST Analysis
  • Figure 11. APAC PEST Analysis
  • Figure 12. MEA PEST Analysis
  • Figure 13. SCAM PEST Analysis
  • Figure 14. Latent TB Detection Market Impact Analysis of Drivers and Restraint
  • Figure 15. Global Latent TB Detection Market - Revenue Forecast And Analysis - 2019- 2027
  • Figure 16. Global Latent TB Detection Market - By Geography Forecast and Analysis - 2019- 2027
  • Figure 17. Market Positioning of Key Players
  • Figure 18. Latent TB Detection Market Share, by Test, 2019 and 2027 (%)
  • Figure 19. Tuberculin Skin Test (TST): Latent TB Detection Market- Revenue and Forecast to 2027 (US$ Million)
  • Figure 20. Interferon Gamma Released Assay (IGRA): Latent TB Detection Market- Revenue and Forecast to 2027 (US$ Million)
  • Figure 21. Latent TB Detection Market Share, by End User, 2019 and 2027 (%)
  • Figure 22. Hospitals: Latent TB Detection Market- Revenue and Forecast to 2027 (US$ Million)
  • Figure 23. Diagnostic Centers: Latent TB Detection Market- Revenue and Forecast to 2027 (US$ Million)
  • Figure 24. Laboratories: Latent TB Detection Market- Revenue and Forecast to 2027 (US$ Million)
  • Figure 25. Others: Latent TB Detection Market- Revenue and Forecast to 2027 (US$ Million)
  • Figure 26. North America: Latent TB Detection Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 27. North America: Latent TB Detection Market, Revenue and Forecast to 2027 (USD Million)
  • Figure 28. North America: Latent TB Detection Market, by Country, 2019 & 2027 (%)
  • Figure 29. US: Latent TB Detection Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 30. Canada: Latent TB Detection Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 31. Mexico: Latent TB Detection Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 32. Europe: Latent TB Detection Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 33. Europe: Latent TB Detection Market, Revenue and Forecast to 2027 (USD Million)
  • Figure 34. Europe: Latent TB Detection Market, by Country, 2019 & 2027 (%)
  • Figure 35. Germany: Latent TB Detection Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 36. UK: Latent TB Detection Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 37. France: Latent TB Detection Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 38. Italy: Latent TB Detection Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 39. Spain: Latent TB Detection Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 40. Rest of Europe: Latent TB Detection Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 41. Asia Pacific: Latent TB Detection Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 42. Asia Pacific Latent TB Detection Market Revenue and Forecast to 2027 (USD Million)
  • Figure 43. Asia Pacific: Latent TB Detection Market, by Country, 2019 & 2027 (%)
  • Figure 44. China: Latent TB Detection Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 45. Japan: Latent TB Detection Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 46. India: Latent TB Detection Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 47. South Korea: Latent TB Detection Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 48. Australia: Latent TB Detection Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 49. Middle East & Africa: Latent TB Detection Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 50. Middle East & Africa Latent TB Detection Market Revenue and Forecast to 2027 (USD Million)
  • Figure 51. Middle East & Africa: Latent TB Detection Market, by Country, 2019 & 2027 (%)
  • Figure 52. Saudi Arabia: Latent TB Detection Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 53. UAE: Latent TB Detection Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 54. South Africa: Latent TB Detection Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 55. South and Central America: Latent TB Detection Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 56. South and Central America Latent TB Detection Market Revenue and Forecast to 2027 (USD Million)
  • Figure 57. South and Central America: Latent TB Detection Market, by Country, 2019 & 2027 (%)
  • Figure 58. Brazil: Latent TB Detection Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 59. Argentina: Latent TB Detection Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 60. Impact of COVID-19 Pandemic in North American Country Markets
  • Figure 61. Impact of COVID-19 Pandemic in European Country Markets
  • Figure 62. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
  • Figure 63. Impact Of COVID-19 Pandemic In Rest of the World Countries Market
  • Figure 64. Growth Strategies Done by the Companies in the Market, (%)
目次
Product Code: TIPRE00014239

The global latent TB detection market is expected to reach US$ 1,684.86 million in 2027 from US$ 1,131.82 million in 2019. The market is estimated to grow with a CAGR of 5.2% from 2020-2027.

The growth of the market is attributed to some key driving factors such as increasing prevalence of tuberculosis and government initiatives to promote tuberculosis detection. However, multidrug resistant tuberculosis (MDR-TB) is likely to hamper the growth of the market to a certain extent.

The patient of latent TB does not show any kind of symptoms even when they are infected by M. tuberculosis. Also, the person suffering from latent TB does not spread the disease. Majorly, tuberculin skin test or TB blood test are recommended for the diagnosis of latent TB infection.

Countries in Asia Pacific and South and Central America are emerging as attractive outsourcing locations for tuberculosis diagnosis. Asian economies, such as India, Indonesia, and China, are among the highest-affected countries with TB. This drives the need for appropriate and advanced diagnostics for TB in these countries. According to the BMJ Medicine, Southeast Asia continues to battle TB as one of the most severe health challenges and does not have sufficient resources for latent TB detection, treatment, and medication facilities. This provides market players with opportunities to build their sustainable bases in these regions and tap the unexplored opportunities.

Low manufacturing and operating costs in China and India offer lucrative opportunities for the growth of diagnostic and therapeutic in the region. Recent growth in the biopharmaceutical industry in both China and India indicates positive future outlook for the market under study. Moreover, the growing domestic market and its advancement of novel technologies are opening up new avenues for contract manufacturers and diagnostic test manufacturers for latent TB detection in APAC.

Based on test, the latent TB detection market was segmented into Tuberculin Skin Test (TST) and Interferon Gamma Released Assay (IGRA). In 2019, the Interferon Gamma Released Assay (IGRA) segment accounted for the highest share in the market and is likely to retain its dominant share. Also, the similar segment is expected to witness fastest growth in the market owing to the accuracy obtained through these tests. The IGRA test has numerous advantages over the TST of not needing the patient to return for test result evaluation. Current IGRAs do not cross-react with most non-TB mycobacteria, including Bacille Calmette-Guerin (BCG) strains.

The COVID-19 pandemic was first reported in December 2019 in Wuhan (China). The COVID-19 pandemic has threatened the national TB programs worldwide. The WHO have also notified that pandemic is threatening to reverse global progress against tuberculosis. The COVID-19 response has affected multiple sectors of public health, recommended preventive screening, and clinical care around the globe.

The Centers for Disease Control and Prevention (CDC), World Health Organization (WHO), European Union (EU), Organization for Economic Co-operation and Development, United States Agency for International Development (USAID), Ministry of Health and Prevention, US Food and Drug Administration (FDA), and Japan TB Surveillance System are a few of the prime secondary sources referred to while preparing this report.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the latent TB detection market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the global latent TB detection market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Latent TB Detection Market - By Test
    • 1.3.2 Latent TB Detection Market - By End User
    • 1.3.3 Latent TB Detection Market - By Geography

2. Latent TB Detection Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Latent TB Detection Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America - PEST Analysis
    • 4.2.2 Europe - PEST Analysis
    • 4.2.3 APAC - PEST Analysis
    • 4.2.4 MEA - PEST Analysis
    • 4.2.5 SCAM - PEST Analysis

5. Latent TB Detection Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increasing Prevalence of Tuberculosis
    • 5.1.2 Government Initiatives to Promote Tuberculosis Detection
  • 5.2 Market Restraints
    • 5.2.1 Emergence of Multidrug Resistant Tuberculosis (MDR-TB)
  • 5.3 Market Opportunities
    • 5.3.1 Emerging Markets
  • 5.4 Future Trends
    • 5.4.1 Advancements in Tuberculosis Diagnosis
  • 5.5 Impact Analysis

6. Latent TB Detection Market - Global Analysis

  • 6.1 Global Latent TB Detection Market Revenue Forecast And Analysis
  • 6.2 Global Latent TB Detection Market, By Geography - Forecast And Analysis
  • 6.3 Market Positioning of Key Players

7. Latent TB Detection Market Analysis - By Test

  • 7.1 Overview
  • 7.2 Latent TB Detection Market Share, by Test, 2019 and 2027 (%)
  • 7.4 Tuberculin Skin Test (TST)
      • 7.4.1.1 Overview
      • 7.4.1.2 Tuberculin Skin Test (TST): Latent TB Detection Market- Revenue and Forecast to 2027 (US$ Million)
  • 7.5 Interferon Gamma Released Assay (IGRA)
      • 7.5.1.1 Overview
      • 7.5.1.2 Interferon Gamma Released Assay (IGRA): Latent TB Detection Market- Revenue and Forecast to 2027 (US$ Million)

8. Latent TB Detection Market Analysis - By End User

  • 8.1 Overview
  • 8.2 Latent TB Detection Market Share, by End User, 2019 and 2027 (%)
  • 8.4 Hospitals
      • 8.4.1.1 Overview
      • 8.4.1.2 Hospitals: Latent TB Detection Market- Revenue and Forecast to 2027 (US$ Million)
  • 8.5 Diagnostic Centers
      • 8.5.1.1 Overview
      • 8.5.1.2 Diagnostic Centers: Latent TB Detection Market- Revenue and Forecast to 2027 (US$ Million)
    • 8.5.2 Laboratories
      • 8.5.2.1 Overview
      • 8.5.2.2 Laboratories: Latent TB Detection Market- Revenue and Forecast to 2027 (US$ Million)
    • 8.5.3 Others
      • 8.5.3.1 Overview
      • 8.5.3.2 Others: Latent TB Detection Market- Revenue and Forecast to 2027 (US$ Million)

9. Latent TB Detection Market Analysis and Forecasts To 2027 - Geographical Analysis

  • 9.1 North America: Latent TB Detection Market
    • 9.1.1 Overview
    • 9.1.2 North America: Latent TB Detection Market, - Revenue and Forecast to 2027 (USD Million)
    • 9.1.3 North America: Latent TB Detection Market, by Test Type - Revenue and Forecast to 2027 (USD Million)
    • 9.1.4 North America: Latent TB Detection Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 9.1.5 North America: Latent TB Detection Market, by Country, 2019 & 2027 (%)
    • 9.1.6 US: Latent TB Detection Market - Revenue and Forecast to 2027 (USD Million)
      • 9.1.6.1 US: Latent TB Detection Market - Revenue and Forecast to 2027 (USD Million)
      • 9.1.6.2 US: Latent TB Detection Market, by Test - Revenue and Forecast to 2027 (USD Million)
      • 9.1.6.3 US: Latent TB Detection Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 9.1.7 Canada: Latent TB Detection Market - Revenue and Forecast to 2027 (USD Million)
      • 9.1.7.1 Canada: Latent TB Detection Market - Revenue and Forecast to 2027 (USD Million)
      • 9.1.7.2 Canada: Latent TB Detection Market, by Test - Revenue and Forecast to 2027 (USD Million)
      • 9.1.7.3 Canada: Latent TB Detection Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 9.1.8 Mexico: Latent TB Detection Market - Revenue and Forecast to 2027 (USD Million)
      • 9.1.8.1 Mexico: Latent TB Detection Market - Revenue and Forecast to 2027 (USD Million)
      • 9.1.8.2 Mexico: Latent TB Detection Market, by Test - Revenue and Forecast to 2027 (USD Million)
      • 9.1.8.3 Mexico: Latent TB Detection Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • 9.2 Europe: Latent TB Detection Market
    • 9.2.1 Overview
    • 9.2.2 Europe: Latent TB Detection Market, - Revenue and Forecast to 2027 (USD Million)
    • 9.2.3 Europe: Latent TB Detection Market, by Test - Revenue and Forecast to 2027 (USD Million)
    • 9.2.4 Europe: Latent TB Detection Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 9.2.5 Europe: Latent TB Detection Market, by Country, 2019 & 2027 (%)
    • 9.2.6 Germany: Latent TB Detection Market - Revenue and Forecast to 2027 (USD Million)
      • 9.2.6.1 Germany: Latent TB Detection Market - Revenue and Forecast to 2027 (USD Million)
      • 9.2.6.2 Germany: Latent TB Detection Market, by Test - Revenue and Forecast to 2027 (USD Million)
      • 9.2.6.3 Germany: Latent TB Detection Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 9.2.7 UK: Latent TB Detection Market - Revenue and Forecast to 2027 (USD Million)
      • 9.2.7.1 UK: Latent TB Detection Market - Revenue and Forecast to 2027 (USD Million)
      • 9.2.7.2 UK: Latent TB Detection Market, by Test - Revenue and Forecast to 2027 (USD Million)
      • 9.2.7.3 UK: Latent TB Detection Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 9.2.8 France: Latent TB Detection Market - Revenue and Forecast to 2027 (USD Million)
      • 9.2.8.1 France: Latent TB Detection Market - Revenue and Forecast to 2027 (USD Million)
      • 9.2.8.2 France: Latent TB Detection Market, by Test - Revenue and Forecast to 2027 (USD Million)
      • 9.2.8.3 France: Latent TB Detection Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 9.2.9 Italy: Latent TB Detection Market - Revenue and Forecast to 2027 (USD Million)
      • 9.2.9.1 Italy: Latent TB Detection Market - Revenue and Forecast to 2027 (USD Million)
      • 9.2.9.2 Italy: Latent TB Detection Market, by Test - Revenue and Forecast to 2027 (USD Million)
      • 9.2.9.3 Italy: Latent TB Detection Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 9.2.10 Spain: Latent TB Detection Market - Revenue and Forecast to 2027 (USD Million)
      • 9.2.10.1 Spain: Latent TB Detection Market - Revenue and Forecast to 2027 (USD Million)
      • 9.2.10.2 Spain: Latent TB Detection Market, by Test - Revenue and Forecast to 2027 (USD Million)
      • 9.2.10.3 Spain: Latent TB Detection Market, by End User - Revenue and Forecast to 2027 (USD Million)
    • 9.2.11 Rest of Europe: Latent TB Detection Market - Revenue and Forecast to 2027 (USD Million)
      • 9.2.11.1 Rest of Europe: Latent TB Detection Market - Revenue and Forecast to 2027 (USD Million)
      • 9.2.11.2 Rest of Europe: Latent TB Detection Market, by Test - Revenue and Forecast to 2027 (USD Million)
      • 9.2.11.3 Rest of Europe: Latent TB Detection Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • 9.3 Asia Pacific: Latent TB Detection Market
    • 9.3.1 Overview
    • 9.3.2 Asia Pacific: Latent TB Detection Market - Revenue and Forecast to 2027 (USD Million)
    • 9.3.3 Asia Pacific Latent TB Detection Market, by Test- Revenue and Forecast to 2027 (USD Million)
    • 9.3.4 Asia Pacific Latent TB Detection Market, by End User- Revenue and Forecast to 2027 (USD Million)
    • 9.3.5 Asia Pacific: Latent TB Detection Market, by Country, 2019 & 2027 (%)
    • 9.3.6 China: Latent TB Detection Market - Revenue and Forecast to 2027 (USD Million)
      • 9.3.6.1 China: Latent TB Detection Market - Revenue and Forecast to 2027 (USD Million)
      • 9.3.6.2 China Latent TB Detection Market, by Test- Revenue and Forecast to 2027 (USD Million)
      • 9.3.6.3 China Latent TB Detection Market, by End User- Revenue and Forecast to 2027 (USD Million)
    • 9.3.7 Japan: Latent TB Detection Market - Revenue and Forecast to 2027 (USD Million)
      • 9.3.7.1 Japan: Latent TB Detection Market - Revenue and Forecast to 2027 (USD Million)
      • 9.3.7.2 Japan Latent TB Detection Market, by Test- Revenue and Forecast to 2027 (USD Million)
      • 9.3.7.3 Japan Latent TB Detection Market, by End User- Revenue and Forecast to 2027 (USD Million)
    • 9.3.8 India: Latent TB Detection Market - Revenue and Forecast to 2027 (USD Million)
      • 9.3.8.1 India: Latent TB Detection Market - Revenue and Forecast to 2027 (USD Million)
      • 9.3.8.2 India Latent TB Detection Market, by Test- Revenue and Forecast to 2027 (USD Million)
      • 9.3.8.3 India Latent TB Detection Market, by End User- Revenue and Forecast to 2027 (USD Million)
    • 9.3.9 South Korea: Latent TB Detection Market - Revenue and Forecast to 2027 (USD Million)
      • 9.3.9.1 South Korea: Latent TB Detection Market - Revenue and Forecast to 2027 (USD Million)
      • 9.3.9.2 South Korea Latent TB Detection Market, by End User- Revenue and Forecast to 2027 (USD Million)
      • 9.3.9.3 South Korea Latent TB Detection Market, by End User- Revenue and Forecast to 2027 (USD Million)
    • 9.3.10 Australia: Latent TB Detection Market - Revenue and Forecast to 2027 (USD Million)
      • 9.3.10.1 Australia: Latent TB Detection Market - Revenue and Forecast to 2027 (USD Million)
      • 9.3.10.2 Australia Latent TB Detection Market, by Test- Revenue and Forecast to 2027 (USD Million)
      • 9.3.10.3 Australia Latent TB Detection Market, by End User- Revenue and Forecast to 2027 (USD Million)
  • 9.4 Middle East & Africa: Latent TB Detection Market
    • 9.4.1 Overview
    • 9.4.2 Middle East & Africa: Latent TB Detection Market - Revenue and Forecast to 2027 (US$ Million)
    • 9.4.3 Middle East and Africa Latent TB Detection Market, by Test- Revenue and Forecast to 2027 (USD Million)
    • 9.4.4 Middle East and Africa Latent TB Detection Market, by End User- Revenue and Forecast to 2027 (USD Million)
    • 9.4.5 Middle East & Africa: Latent TB Detection Market, by Country, 2019 & 2027 (%)
    • 9.4.6 Saudi Arabia: Latent TB Detection Market - Revenue and Forecast to 2027 (USD Million)
      • 9.4.6.1 Saudi Arabia: Latent TB Detection Market - Revenue and Forecast to 2027 (USD Million)
      • 9.4.6.2 Saudi Arabia Latent TB Detection Market, by Test- Revenue and Forecast to 2027 (USD Million)
      • 9.4.6.3 Saudi Arabia Latent TB Detection Market, by End User- Revenue and Forecast to 2027 (USD Million)
    • 9.4.7 UAE: Latent TB Detection Market - Revenue and Forecast to 2027 (USD Million)
      • 9.4.7.1 UAE: Latent TB Detection Market - Revenue and Forecast to 2027 (USD Million)
      • 9.4.7.2 UAE Latent TB Detection Market, by Test- Revenue and Forecast to 2027 (USD Million)
      • 9.4.7.3 UAE Latent TB Detection Market, by End User- Revenue and Forecast to 2027 (USD Million)
    • 9.4.8 South Africa: Latent TB Detection Market - Revenue and Forecast to 2027 (USD Million)
      • 9.4.8.1 South Africa: Latent TB Detection Market - Revenue and Forecast to 2027 (USD Million)
      • 9.4.8.2 South Africa Latent TB Detection Market, by Test- Revenue and Forecast to 2027 (USD Million)
      • 9.4.8.3 South Africa Latent TB Detection Market, by End User- Revenue and Forecast to 2027 (USD Million)
  • 9.5 South and Central America: Latent TB Detection Market
    • 9.5.1 Overview
    • 9.5.2 South and Central America: Latent TB Detection Market - Revenue and Forecast to 2027 (USD Million)
    • 9.5.3 South and Central America Latent TB Detection Market, by Test- Revenue and Forecast to 2027 (USD Million)
    • 9.5.4 South and Central America Latent TB Detection Market, by End User- Revenue and Forecast to 2027 (USD Million)
    • 9.5.5 South and Central America: Latent TB Detection Market, by Country, 2019 & 2027 (%)
    • 9.5.6 Brazil: Latent TB Detection Market - Revenue and Forecast to 2027 (USD Million)
      • 9.5.6.1 Brazil: Latent TB Detection Market - Revenue and Forecast to 2027 (USD Million)
      • 9.5.6.2 Brazil Latent TB Detection Market, by Test- Revenue and Forecast to 2027 (USD Million)
      • 9.5.6.3 Brazil Latent TB Detection Market, by End User- Revenue and Forecast to 2027 (USD Million)
    • 9.5.7 Argentina: Latent TB Detection Market - Revenue and Forecast to 2027 (USD Million)
      • 9.5.7.1 Argentina: Latent TB Detection Market - Revenue and Forecast to 2027 (USD Million)
      • 9.5.7.2 Argentina Latent TB Detection Market, by Test- Revenue and Forecast to 2027 (USD Million)
      • 9.5.7.3 Argentina Latent TB Detection Market, by End User- Revenue and Forecast to 2027 (USD Million)

10. Impact of COVID-19 Pandemic on Global Latent TB Detection Market

  • 10.1 North America: Impact Assessment of COVID-19 Pandemic
  • 10.2 Europe: Impact Assessment Of COVID-19 Pandemic
  • 10.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
  • 10.4 Rest of the World: Impact Assessment of COVID-19 Pandemic

11. Latent TB Detection Market - Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies Done by the Companies in the Market, (%)
  • 11.3 Organic Developments
    • 11.3.1 Overview
  • 11.4 Inorganic Developments
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 QIAGEN
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 bioMerieux SA
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 F. HOFFMANN-LA ROCHE LTD.
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 BD
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Abbott
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Oxford Immunotec Ltd
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Lionex GmbH
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 ARKRAY, Inc.
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Serum Institute of India Pvt. Ltd
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 Glossary of Terms